NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Effect of Nicorandil in Type 2 Diabetic Obese Patients
Effect of Nicorandil in Type 2 Diabetic Obese Patients
CompletedPhase 2
Sponsor: Tanta University
Conditions: Diabetes Mellitus, Type 2
Interventions: Nicorandil 10 MG
Countries: Egypt
1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.
Eligibility overview
Sex: ALL
Age: 18 Years to 60 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Patients newly diagnosed with diabetes . * Body mass index (BMI) \>30 Kg/m2. * The selected patients are treated with sulfonylureas alone. * The age of selected patient ranged from 18 and 60 years. Exclusion Criteria: * Pregnant and lactating females. * Patients with hypersensitivity to nicorandil. * Uncontrolled hypertension and its antihypertensive medications * Severe renal or hepatic disease.
Locations (1)
- Tanta, Egypt